ArticleLeukemia2019
Targeting nuclear β-catenin as therapy for post-myeloproliferative neoplasm secondary AML.
Dyana T Saenz et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
30 papers cite it
this papercites it
ArticleLeukemia2019
Dyana T Saenz et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.